Discharge to Assess Community Beds

Opportunity overview

Additional Pathway 3 beds will be included in the contract from 1 July 2026. These additional beds are reflected in the contract values below and apply for 15 months of the initial contract term. The total expected value of the contract for the initial 18‑month term is £894,326.17 (excluding VAT). The expected value of the optional 12‑month extension is £636,604.01 (excluding VAT). The total expected lifetime value of the contract (18‑month initial term plus optional 12‑month extension) is therefore £1,530,930.18 (excluding VAT). The services being procured constitute VAT‑exempt welfare services provided by a registered care home. The contract commenced on 1 April 2026, and the modification takes effect from 1 July 2026.

Awarded to

Amounts belong to published awards or contracts. Where several suppliers share one value, it is labelled as shared and is not a supplier-specific allocation.

Classification

• CPV85144000 — Residential health facilities services

Lots

• NHS Bristol, North Somerset and South Gloucestershire ICB ("the Commissioner") sought to commission the block provision of Pathway 3 (P3) Discharge to Assess Community Beds for patients in BNSSG. Pathway 3 supports people who require approximately 28 days of intensive rehabilitation in a community hospital or nursing/residential care home setting and who are expected to require a long‑term care package, most likely in a nursing or residential care home. BNSSG ICB has implemented a Discharge to Assess model in collaboration with ICS partners, incorporating four pathways (0-3) to support timely discharge from hospital and maximise independence. Pathway 3 forms part of this wider system.Value not stated